Search
The FDA has approved the first-ever treatment developed for low-grade serous ovarian cancer, a rare type of ovarian cancer.
Learn about how The Society of Memorial Sloan Kettering is supporting precision medicine at MSK Kids.
Mutations in a gene called FOXA1 are responsible for a distinct class of prostate cancer tumors, MSK researchers have found.
Antibody-drug conjugates and checkpoint inhibitors show promise as new therapies for bladder cancer.
RSV is a respiratory disease that spreads in the fall and winter months. Learn about the RSV vaccines, which are approved for people ages 50 and older.
Memorial Sloan Kettering and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.
An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.
Learn about lung cancer in women, the links between lung cancer and smoking, the relationship between lung cancer and genetics, and the benefits of being treated at a hospital that offers many clinical trials for lung cancer.
Infórmese sobre el cáncer pulmonar en mujeres, la conexión entre el cáncer pulmonar y el tabaquismo, la relación entre el cáncer pulmonar y la genética, y los beneficios de recibir tratamiento en un hospital que ofrece numerosos ensayos clínicos para el cáncer pulmonar.
Tune in to today’s “MSK Science Spotlight.” The April 20 lecture, “A Single Cell Lens into the Roles of Cellular Plasticity in Development and Cancer,” will feature Dana Pe’er, PhD.